Close Icon
 
Scheduled maintenance work on Thursday 19th January 2016 between 00:00 and 06:00 hours (GMT)
One of our internet service providers will be performing maintenance upgrade work on their network which means you may experience an intermittent reduction in performance, with the possibility of our publishing platform services being offline temporarily. If you have any questions, please use the feedback button on this page. We apologise for any inconvenience this might cause and thank you for your patience.

Physical Chemistry Chemical Physics

High quality research in physical chemistry, chemical physics and biophysical chemistry.

Perspective

Alzheimer's disease: which type of amyloid-preventing drug agents to employ?

*
Corresponding authors
a
Center for Cancer Research, Nanobiology Program, Basic Science Program, SAIC-Frederick, Inc., National Cancer Institute, Frederick, USA
E-mail: nussinor@helix.nih.gov
b
Departments of Bioengineering and of Mechanical and Aerospace Engineering, and Materials Science Program, University of California, San Diego, La Jolla, USA
c
Department of Psychiatry, David Geffen School of Medicine, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, USA
E-mail: bkagan@mednet.ucla.edu
d
Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University, Tel Aviv 69978, Israel
Phys. Chem. Chem. Phys., 2013,15, 8868-8877

DOI: 10.1039/C3CP00017F
Received 02 Jan 2013, Accepted 20 Feb 2013
First published online 21 Feb 2013

This article is part of themed collection: Biophysical studies on protein misfolding and amyloid diseases
Please wait while Download options loads